{"id":347,"date":"2020-07-02T06:57:53","date_gmt":"2020-07-02T13:57:53","guid":{"rendered":"https:\/\/derm-biomepharmaceuticals.com\/?p=347"},"modified":"2020-10-23T07:00:13","modified_gmt":"2020-10-23T14:00:13","slug":"derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases","status":"publish","type":"post","link":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/","title":{"rendered":"Derm-Biome Pharmaceuticals, Inc \u7c4c\u96c6\u7a2e\u5b50\u524d\u8cc7\u91d1\uff0c\u6210\u7acb\u5c08\u6ce8\u65bc\u6162\u6027\u767c\u708e\u75be\u75c5\u7684\u65b0\u516c\u53f8"},"content":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]<\/p>\n<div class=\"page\" title=\"\u7b2c1\u9801\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>\u4e0d\u5217\u985b\u54e5\u502b\u6bd4\u4e9e\u7701\u6eab\u54e5\u83ef\uff0c2020 \u5e747 \u67082 \u65e5(\u74b0\u7403\u901a\u8a0a\u793e) \u2014 Derm-Biome Pharmaceuticals, Inc \u662f\u4e00\u5bb6\u7e3d\u90e8\u4f4d\u65bc\u6eab\u54e5\u83ef\u3001\u5c08\u6ce8\u65bc\u76ae\u819a\u75c5\u548c\u5065\u5eb7\u8001\u9f61\u5316\u7684\u81e8\u5e8a\u524d\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u5f88\u9ad8\u8208\u5730\u5ba3\u5e03\u5df2\u5728\u7a2e\u5b50\u524d\u878d\u8cc7$500,000 \u8f2a\u878d\u8cc7\u8cc7\u91d1\uff0c\u8cc7\u91d1\u5c07\u4f7f\u5176\u80fd\u5920\u5728 2021 \u5e74\u7b2c\u4e00\u5b63\u4e4b\u524d\u5c07\u5176\u6297\u8870\u8001\uff08\u76ae\u819a\u518d\u751f\uff09\u548c\u7570\u4f4d\u6027\u76ae\u819a\u708e\u5916\u7528\u85e5\u7269\u63a8\u5411\u81e8\u5e8a\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u4e00\u5bb6\u540d\u70ba Pan-Biome Pharmaceuticals, Inc. \u7684\u65b0\u7684\u7368\u7acb\u751f\u7269\u6280\u8853\u516c\u53f8\u4e5f\u5df2\u5206\u62c6\u51fa\u4f86\uff0c\u5c07\u5c08\u6ce8\u65bc\u958b\u767c\u6cbb\u7642\u6162\u6027\u767c\u708e\u75be\u75c5\u7684\u85e5\u7269\u3002\u65b0\u516c\u53f8\u5c07\u5f9e\u65e9\u671f\u5c0f\u5206\u5b50\u958b\u59cb\uff0c\u9019\u4e9b\u5c0f\u5206\u5b50\u5728\u81e8\u5e8a\u524d\u7814\u7a76\u4e2d\u5df2\u8b49\u660e\u5177\u6709\u5f37\u5927\u7684\u6297\u767c\u708e\u6d3b\u6027\uff0c\u53ef\u6291\u5236\u8a31\u591a\u6162\u6027\u767c\u708e\u75be\u75c5\u4e2d\u904e\u5ea6\u8868\u9054\u7684\u7d30\u80de\u56e0\u5b50\u7684\u7522\u751f\u3002\u9019\u4e9b\u5316\u5408\u7269\u9084\u5177\u6709\u6297\u83cc\u6d3b\u6027\uff0c\u53ef\u80fd\u6709\u52a9\u65bc\u8178\u9053\u5fae\u751f\u7269\u7d44\u7684\u5e73\u8861\u548c\u591a\u6a23\u5316\u3002<\/p>\n<p>\u6162\u6027\u767c\u708e\u5728\u6211\u5011\u9019\u500b\u6642\u4ee3\u6700\u5177\u6311\u6230\u6027\u7684\u75be\u75c5\u4e2d\u767c\u63ee\u8457\u6838\u5fc3\u4f5c\u7528\uff0c\u5305\u62ec\u985e\u98a8\u6fd5\u6027\u95dc\u7bc0\u708e\u3001\u764c\u75c7\u3001\u5fc3\u81df\u75c5\u3001\u7cd6\u5c3f\u75c5\u3001\u6c23\u5598\u548c\u963f\u8332\u6d77\u9ed8\u75c7\u3002\u8178\u9053\u5fae\u751f\u7269\u7fa4\u7d44\u6210\u7684\u6539\u8b8a\u8207\u767c\u708e\u6027\u75be\u75c5\u6709\u95dc\uff0c\u5982\u767c\u708e\u6027\u8178\u9053\u75be\u75c5\u3001\u80a5\u80d6\u3001\u809d\u75c5\u3001\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u5927\u8178\u764c\u3002\u6162\u6027\u767c\u708e\u9032\u5c55\u7de9\u6162\uff0c\u4f46\u5b83\u662f\u5927\u591a\u6578\u6162\u6027\u75be\u75c5\u7684\u539f\u56e0\uff0c\u4e26\u5c0d\u500b\u4eba\u7684\u5065\u5eb7\u548c\u58fd\u547d\u69cb\u6210\u91cd\u5927\u5a01\u8105\u3002<\/p>\n<p>Derm-Biome \u57f7\u884c\u9577 Gordon Eberwein \u8868\u793a\uff1a\u300c\u7531\u65bc\u6211\u5011\u7684\u5316\u5408\u7269\u5177\u6709\u5ee3\u6cdb\u7684\u6297\u767c\u708e\u548c\u6297\u83cc\u7279\u6027\uff0c\u6211\u5011\u5c0d Pan-Biome \u7684\u524d\u666f\u611f\u5230\u975e\u5e38\u8208\u596e\u3002\u6211\u5011\u4e5f\u671f\u5f85\u8207\u65b0\u6295\u8cc7\u8005\u5408\u4f5c\uff0c\u4ed6\u5011\u5e36\u4f86\u4e86\u751f\u547d\u79d1\u5b78\u9818\u57df\u8c50\u5bcc\u7684\u878d\u8cc7\u548c\u4f75\u8cfc\u7d93\u9a57\u3002\u201d<\/p>\n<p>Pan-Biome \u5c07\u65bc\u4eca\u5e74\u590f\u5929\u665a\u4e9b\u6642\u5019\u958b\u59cb\u5c0d\u5404\u7a2e\u9069\u61c9\u75c7\u7684\u81e8\u5e8a\u524d\u6a21\u578b\u9032\u884c\u6e2c\u8a66\uff0c\u5305\u62ec\u4f7f\u7528\u65b0\u7684\u8f38\u9001\u7cfb\u7d71\uff0c\u8a72\u7cfb\u7d71\u5c07\u5141\u8a31\u66f4\u5927\u3001\u66f4\u6709\u91dd\u5c0d\u6027\u7684\u85e5\u7269\u8ca0\u8f09\u3002\u81e8\u5e8a\u8a66\u9a57\u7533\u8acb\u9810\u8a08\u5c07\u65bc2021\u5e74\u4e0a\u534a\u5e74\u63d0\u51fa\u3002<\/p>\n<p><strong>\u95dc\u65bc Derm-Biome \u88fd\u85e5\u516c\u53f8<\/strong><\/p>\n<p>Derm-Biome Pharmaceuticals, Inc. \u662f\u4e00\u5bb6\u81e8\u5e8a\u524d\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u64c1\u6709 40 \u591a\u7a2e\u5929\u7136\u5316\u5408\u7269\u884d\u751f\u7269\u3001\u9e7d\u548c\u5171\u6676\uff0c\u81f4\u529b\u65bc\u6539\u5584\u76ae\u819a\u5065\u5eb7\u548c\u5065\u5eb7\u8001\u5316\u3002\u6211\u5011\u7684\u5316\u5408\u7269\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5177\u6709\u65b0\u7a4e\u7684\u6297\u767c\u708e\u3001\u6297\u83cc\u3001\u6297\u6c27\u5316\u548c\u6297\u816b\u7624\u7279\u6027\u3002<\/p>\n<p><strong>\u63a5\u89f8<\/strong><br \/>\n\u6295\u8cc7\u8005\u53ca\u5408\u4f5c\u8aee\u8a62\uff1a<br \/>\n\u6208\u767b\u00b7\u827e\u4f2f\u6eab<br \/>\n<a title=\"\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=TvN3AjyMy5FFtxRfqR_wzQwC7a643uxh9kgStSnL4iPv1m4WNgzp6bbQx71g9rRjb16p6HQqtpfRzLMzGYdXuCSm_wkLpRtMAn7MzMG8B0Q=\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><u>geberwein@derm-biome.com<\/u><\/a><br \/>\n<a title=\"\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=tGdZQfzns6XrHAMbeEhOn0L1r5YuTwO8Wz_MaRfh4Ewe_dhGWI8_ILFF7ly4vCXnLZ9hBcXL44ucH5lWrzkQaxcOtgI-4q-Iv_G5779SMCIZ_0Ow-NxS9xkA0AOyCkM8OS-bwejDkm9cg4Cm-m8p4Q==\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><u>https:\/\/derm-biomepharmaceuticals.com\/<\/u><\/a><br \/>\n<a title=\"\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=tGdZQfzns6XrHAMbeEhOn5sziGO-teS0_E7MTujPdq1tRdTNsBk5VgWnoZgAd_m3BCkW-yqznfpjWKcnrCqWsFV-QQy0fZk4qgLRrO8eGAf-3_8EYxbJ8aElPjT8gKuh\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><u>https:\/\/pan-biomepharmaceuticals.com\/<\/u><\/a><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>","protected":false},"excerpt":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) &#8212; Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin diseases and healthy ageing, is pleased to announce that it has raised $500,000 in pre-seed funding, monies that will allow it to advance its anti-aging (skin [&hellip;]<\/p>","protected":false},"author":2,"featured_media":348,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recent-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases - Derm-Biome Pharmaceuticals Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"zh_HK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases - Derm-Biome Pharmaceuticals Inc.\" \/>\n<meta property=\"og:description\" content=\"[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) &#8212; Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin diseases and healthy ageing, is pleased to announce that it has raised $500,000 in pre-seed funding, monies that will allow it to advance its anti-aging (skin [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"Derm-Biome Pharmaceuticals Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-02T13:57:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-23T14:00:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"539\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Derm-Biome Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Derm-Biome Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u8a08\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\"},\"author\":{\"name\":\"Derm-Biome Admin\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d\"},\"headline\":\"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases\",\"datePublished\":\"2020-07-02T13:57:53+00:00\",\"dateModified\":\"2020-10-23T14:00:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\"},\"wordCount\":413,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg\",\"articleSection\":[\"Recent News\"],\"inLanguage\":\"zh-HK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\",\"name\":\"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases - Derm-Biome Pharmaceuticals Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg\",\"datePublished\":\"2020-07-02T13:57:53+00:00\",\"dateModified\":\"2020-10-23T14:00:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#breadcrumb\"},\"inLanguage\":\"zh-HK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg\",\"contentUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg\",\"width\":1000,\"height\":539},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/derm-biomepharmaceuticals.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#website\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/\",\"name\":\"Derm-Biome Pharmaceuticals Inc.\",\"description\":\"Startup Biopharmaceutical Company\",\"publisher\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/derm-biomepharmaceuticals.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-HK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#organization\",\"name\":\"Derm-Biome Pharmaceuticals\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png\",\"contentUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png\",\"width\":450,\"height\":200,\"caption\":\"Derm-Biome Pharmaceuticals\"},\"image\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d\",\"name\":\"Derm-Biome Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g\",\"caption\":\"Derm-Biome Admin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases - Derm-Biome Pharmaceuticals Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/","og_locale":"zh_HK","og_type":"article","og_title":"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases - Derm-Biome Pharmaceuticals Inc.","og_description":"[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) &#8212; Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin diseases and healthy ageing, is pleased to announce that it has raised $500,000 in pre-seed funding, monies that will allow it to advance its anti-aging (skin [&hellip;]","og_url":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/","og_site_name":"Derm-Biome Pharmaceuticals Inc.","article_published_time":"2020-07-02T13:57:53+00:00","article_modified_time":"2020-10-23T14:00:13+00:00","og_image":[{"width":1000,"height":539,"url":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg","type":"image\/jpeg"}],"author":"Derm-Biome Admin","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Derm-Biome Admin","\u9810\u8a08\u95b1\u8b80\u6642\u9593":"2 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#article","isPartOf":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/"},"author":{"name":"Derm-Biome Admin","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d"},"headline":"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases","datePublished":"2020-07-02T13:57:53+00:00","dateModified":"2020-10-23T14:00:13+00:00","mainEntityOfPage":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/"},"wordCount":413,"commentCount":0,"publisher":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#organization"},"image":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg","articleSection":["Recent News"],"inLanguage":"zh-HK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/","url":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/","name":"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases - Derm-Biome Pharmaceuticals Inc.","isPartOf":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage"},"image":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg","datePublished":"2020-07-02T13:57:53+00:00","dateModified":"2020-10-23T14:00:13+00:00","breadcrumb":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#breadcrumb"},"inLanguage":"zh-HK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#primaryimage","url":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg","contentUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2020\/10\/Announcement-Photo-2020Oct.jpg","width":1000,"height":539},{"@type":"BreadcrumbList","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-raises-pre-seed-funding-spins-out-new-company-focused-on-chronic-inflammatory-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/derm-biomepharmaceuticals.com\/"},{"@type":"ListItem","position":2,"name":"Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases"}]},{"@type":"WebSite","@id":"https:\/\/derm-biomepharmaceuticals.com\/#website","url":"https:\/\/derm-biomepharmaceuticals.com\/","name":"Derm-Biome Pharmaceuticals Inc.","description":"Startup Biopharmaceutical Company","publisher":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/derm-biomepharmaceuticals.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-HK"},{"@type":"Organization","@id":"https:\/\/derm-biomepharmaceuticals.com\/#organization","name":"Derm-Biome Pharmaceuticals","url":"https:\/\/derm-biomepharmaceuticals.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/","url":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png","contentUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png","width":450,"height":200,"caption":"Derm-Biome Pharmaceuticals"},"image":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d","name":"Derm-Biome Admin","image":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g","caption":"Derm-Biome Admin"}}]}},"_links":{"self":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/posts\/347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/comments?post=347"}],"version-history":[{"count":1,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/posts\/347\/revisions"}],"predecessor-version":[{"id":350,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/posts\/347\/revisions\/350"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/media\/348"}],"wp:attachment":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/media?parent=347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/categories?post=347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch-s\/wp-json\/wp\/v2\/tags?post=347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}